Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.450
-0.181 (-6.88%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Alaunos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1.09 | 6.06 | 39.06 | 76.05 | 115.07 | Upgrade
|
| Cash & Short-Term Investments | 1.09 | 6.06 | 39.06 | 76.05 | 115.07 | Upgrade
|
| Cash Growth | -82.00% | -84.48% | -48.64% | -33.91% | 44.30% | Upgrade
|
| Accounts Receivable | 0.01 | 0 | 0 | 1.11 | - | Upgrade
|
| Other Receivables | - | - | - | - | 4.67 | Upgrade
|
| Receivables | 0.01 | 0 | 0 | 1.11 | 4.67 | Upgrade
|
| Prepaid Expenses | 1.66 | 2.2 | 0.8 | 1.67 | 2.76 | Upgrade
|
| Restricted Cash | - | - | 13.94 | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | 8.1 | Upgrade
|
| Total Current Assets | 2.76 | 8.26 | 53.8 | 78.83 | 130.59 | Upgrade
|
| Property, Plant & Equipment | - | 0 | 10.6 | 15.36 | 14.88 | Upgrade
|
| Other Long-Term Assets | - | - | 0.54 | 0.67 | 0.88 | Upgrade
|
| Total Assets | 2.76 | 8.26 | 64.94 | 94.87 | 146.35 | Upgrade
|
| Accounts Payable | 0.52 | 0.62 | 1.39 | 1.37 | 0.96 | Upgrade
|
| Accrued Expenses | 0.18 | 1.34 | 5.45 | 6.08 | 16.59 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 16.77 | 7.87 | - | Upgrade
|
| Current Portion of Leases | - | - | 0.56 | 0.73 | 0.82 | Upgrade
|
| Total Current Liabilities | 0.69 | 1.96 | 24.17 | 16.04 | 18.37 | Upgrade
|
| Long-Term Debt | - | - | - | 16.25 | - | Upgrade
|
| Long-Term Leases | - | - | 2.19 | 4.52 | 4 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.03 | -0 | - | Upgrade
|
| Total Liabilities | 0.69 | 1.96 | 26.38 | 36.81 | 22.36 | Upgrade
|
| Common Stock | 0 | 0 | 0.02 | 0.22 | 0.22 | Upgrade
|
| Additional Paid-In Capital | 922.51 | 922.07 | 919.17 | 900.69 | 887.87 | Upgrade
|
| Retained Earnings | -920.45 | -915.77 | -880.63 | -842.85 | -764.1 | Upgrade
|
| Total Common Equity | 2.06 | 6.31 | 38.56 | 58.06 | 123.98 | Upgrade
|
| Shareholders' Equity | 2.06 | 6.31 | 38.56 | 58.06 | 123.98 | Upgrade
|
| Total Liabilities & Equity | 2.76 | 8.26 | 64.94 | 94.87 | 146.35 | Upgrade
|
| Total Debt | - | - | 19.51 | 29.37 | 4.81 | Upgrade
|
| Net Cash (Debt) | 1.09 | 6.06 | 19.55 | 46.69 | 110.26 | Upgrade
|
| Net Cash Growth | -82.00% | -68.99% | -58.13% | -57.65% | 42.47% | Upgrade
|
| Net Cash Per Share | 0.68 | 3.79 | 13.50 | 32.66 | 78.89 | Upgrade
|
| Filing Date Shares Outstanding | 1.6 | 1.6 | 1.6 | 1.43 | 1.43 | Upgrade
|
| Total Common Shares Outstanding | 1.6 | 1.6 | 1.6 | 1.43 | 1.43 | Upgrade
|
| Working Capital | 2.06 | 6.31 | 29.63 | 62.79 | 112.22 | Upgrade
|
| Book Value Per Share | 1.29 | 3.94 | 24.15 | 40.52 | 86.98 | Upgrade
|
| Tangible Book Value | 2.06 | 6.31 | 38.56 | 58.06 | 123.98 | Upgrade
|
| Tangible Book Value Per Share | 1.29 | 3.94 | 24.15 | 40.52 | 86.98 | Upgrade
|
| Machinery | 0.02 | 0.02 | 7.42 | 7.64 | 6.27 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.31 | Upgrade
|
| Leasehold Improvements | - | - | 9.56 | 9.47 | 7.46 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.